Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Black Diamond Therapeutics Inc., 2 years.
Black Diamond Therapeutics Inc.
Director
Olema Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 19, 2026 | Black Diamond Therapeutics Inc. | Grant or award | +7,907 | $1.66 | $13,126 |
| Mar 20, 2026 | Black Diamond Therapeutics Inc. | Grant or award | +6,105 | $2.15 | $13,126 |
| Dec 12, 2025 | Black Diamond Therapeutics Inc. | Grant or award | +4,665 | $2.76 | $12,875 |
| Sep 19, 2025 | Black Diamond Therapeutics Inc. | Grant or award | +3,843 | $3.35 | $12,874 |
| Jun 20, 2025 | Black Diamond Therapeutics Inc. | Grant or award | +5,526 | $2.33 | $12,876 |
| Mar 21, 2025 | Black Diamond Therapeutics Inc. | Grant or award | +6,848 | $1.88 | $12,874 |
| Dec 13, 2024 | Black Diamond Therapeutics Inc. | Grant or award | +5,150 | $2.50 | $12,875 |
| Sep 20, 2024 | Black Diamond Therapeutics Inc. | Grant or award | +2,694 | $4.78 | $12,877 |
| Jun 21, 2024 | Black Diamond Therapeutics Inc. | Grant or award | +2,301 | $4.98 | $11,459 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.